These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 14564148)

  • 1. Pharmacotherapy in congestive heart failure: drug absorption in the management of congestive heart failure: loop diuretics.
    Sica DA
    Congest Heart Fail; 2003; 9(5):287-92. PubMed ID: 14564148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of the loop diuretic torsemide in three dogs with advanced heart failure.
    Oyama MA; Peddle GD; Reynolds CA; Singletary GE
    J Vet Cardiol; 2011 Dec; 13(4):287-92. PubMed ID: 22030290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A pharmacoeconomic assessment of torsemide and furosemide in the treatment of patients with congestive heart failure.
    Noe LL; Vreeland MG; Pezzella SM; Trotter JP
    Clin Ther; 1999 May; 21(5):854-66. PubMed ID: 10397380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Torsemide: a pyridine-sulfonylurea loop diuretic.
    Blose JS; Adams KF; Patterson JH
    Ann Pharmacother; 1995 Apr; 29(4):396-402. PubMed ID: 7633019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Open-label randomized trial of torsemide compared with furosemide therapy for patients with heart failure.
    Murray MD; Deer MM; Ferguson JA; Dexter PR; Bennett SJ; Perkins SM; Smith FE; Lane KA; Adams LD; Tierney WM; Brater DC
    Am J Med; 2001 Nov; 111(7):513-20. PubMed ID: 11705426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of torsemide and furosemide on clinical, laboratory, radiographic and quality of life variables in dogs with heart failure secondary to mitral valve disease.
    Peddle GD; Singletary GE; Reynolds CA; Trafny DJ; Machen MC; Oyama MA
    J Vet Cardiol; 2012 Mar; 14(1):253-9. PubMed ID: 22364690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal diuretic therapy for heart failure.
    Cohn JN
    Am J Med; 2001 Nov; 111(7):577. PubMed ID: 11705437
    [No Abstract]   [Full Text] [Related]  

  • 8. Renal excretory profiles of loop diuretics: consequences for therapeutic application.
    Reyes AJ
    J Cardiovasc Pharmacol; 1993; 22 Suppl 3():S11-23. PubMed ID: 7506333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Torasemide (LUPRAC): a review of its pharmacological and clinical profile].
    Kido H; Ohtaki Y
    Nihon Yakurigaku Zasshi; 2001 Aug; 118(2):97-105. PubMed ID: 11530685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioavailability, pharmacokinetics, and pharmacodynamics of torsemide and furosemide in patients with congestive heart failure.
    Vargo DL; Kramer WG; Black PK; Smith WB; Serpas T; Brater DC
    Clin Pharmacol Ther; 1995 Jun; 57(6):601-9. PubMed ID: 7781259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Six-week study of torsemide in patients with congestive heart failure.
    Goebel KM
    Clin Ther; 1993; 15(6):1051-9. PubMed ID: 8111802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pharmacodynamics of torsemide in patients with congestive heart failure.
    Vargo D; Kramer WG; Black PK; Smith WB; Serpas T; Brater DC
    Clin Pharmacol Ther; 1994 Jul; 56(1):48-54. PubMed ID: 8033494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can Torsemide and Combination of Loop Diuretics Improve Mortality in Patients with Chronic Heart Failure After Discharge?
    Yao Y; Zhang J; Zhang Y; Zhang R
    Int Heart J; 2018 Jul; 59(4):813-820. PubMed ID: 29877310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Torsemide: a new loop diuretic.
    Fowler SF; Murray KM
    Am J Health Syst Pharm; 1995 Aug; 52(16):1771-80; quiz 1814-5. PubMed ID: 8528833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative Effect of Loop Diuretic Prescription on Mortality and Heart Failure Readmission.
    Virkud AV; Chang PP; Funk MJ; Kshirsagar AV; Edwards JK; Pate V; Kosorok MR; Gower EW
    Am J Cardiol; 2024 Jan; 210():208-216. PubMed ID: 37972425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose-response study of intravenous torsemide in congestive heart failure.
    Hariman RJ; Bremner S; Louie EK; Rogers WJ; Kostis JB; Nocero MA; Jones JP
    Am Heart J; 1994 Aug; 128(2):352-7. PubMed ID: 8037103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loop diuretics in patients with heart failure: time to change to torsemide?
    Pitt B; Nicklas J
    J Cardiovasc Pharmacol; 2009 Jun; 53(6):435-7. PubMed ID: 19430308
    [No Abstract]   [Full Text] [Related]  

  • 18. Torasemide for the treatment of heart failure.
    Ishido H; Senzaki H
    Cardiovasc Hematol Disord Drug Targets; 2008 Jun; 8(2):127-32. PubMed ID: 18537599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Torasemide versus furosemide in cirrhosis: a long-term, double-blind, randomized clinical study.
    Fiaccadori F; Pedretti G; Pasetti G; Pizzaferri P; Elia G
    Clin Investig; 1993 Jul; 71(7):579-84. PubMed ID: 8374255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of short-acting and long-acting loop diuretics on heart rate variability in patients with chronic compensated congestive heart failure.
    Tomiyama H; Nakayama T; Watanabe G; Shiojima K; Sakuma Y; Yamamoto A; Imai Y; Yoshida H; Doba N
    Am Heart J; 1999 Mar; 137(3):543-8. PubMed ID: 10047639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.